Composition for testing for porcine reproductive and respiratory syndrome virus, test kit, and test method using same
The use of specific probes and primers in an RT-qPCR method addresses the challenge of high mutation rates in PRRSv diagnostics, enabling accurate differentiation of PRRSv types and ensuring sample integrity, thus improving diagnostic accuracy and agreement with standard sequencing results.
Patent Information
- Application Number
- PCT/KR2024/007264
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-31
- Filing Date
- 2024-05-28
- Publication Date
- 2024-12-05
AI Technical Summary
Current diagnostic methods for porcine reproductive and respiratory syndrome virus (PRRSv) struggle with high mutation rates, leading to false negative results due to mutations at primer and probe attachment sites, and lack effectiveness in distinguishing between PRRSv types 1 and 2.
A composition and test kit using specific probes and primers (represented by SEQ ID NOs) for RT-qPCR, designed to effectively diagnose PRRSv types 1 and 2, with additional probes and primers for confirming sample purity and concentration, enabling accurate differentiation of PRRSv types.
The solution allows for accurate detection of PRRSv types 1 and 2 with high sensitivity and specificity, even in the presence of mutations, and confirms the purity and concentration of samples, outperforming existing methods in diagnostic accuracy and agreement with standard sequencing results.
Smart Images

Figure KR2024007264_05122024_PF_FP_ABST
Abstract
Description
Composition for testing porcine reproductive and respiratory syndrome virus, test kit and test method using the same
[0001] The present invention relates to a composition for virus testing, a test kit, and a test method using the same, and more specifically, to a composition for porcine reproductive and respiratory syndrome virus testing, a test kit, and a test method using the same.
[0002] The content described in this section merely provides background information for one embodiment of the present invention and does not constitute prior art.
[0003]
[0004] Porcine reproductive and respiratory syndrome (PRRS) is a viral swine disease that began in the late 1980s in sows in North America and Europe and is characterized by reproductive failure, respiratory disease at all ages, reduced growth rate, and increased mortality. It is now endemic in most pig-producing countries and poses a serious threat to the pig industry worldwide. The pathogen is the porcine reproductive and respiratory syndrome virus (PRRS virus, PRRSv).
[0005]
[0006] PRRSv can be broadly divided into two genotypes: European (Type 1) and North American (Type 2), which differ by over 40% in their overall sequence. As the genotype names suggest, Type 1 was identified in Europe, while Type 2 was identified in North America, leading to global outbreaks. The economic damage caused by this disease is reported to be approximately 100 billion won annually in South Korea and $600 million in the United States.
[0007]
[0008] In Korea, PRRS is managed as a Class 3 livestock infectious disease, and related organizations and producers are paying close attention to its declining productivity. For prevention and countermeasures, the method of PRRS elimination is to close pig herds for a certain period without introducing gilts. Appropriate measures are needed depending on the farm's situation, so the infection situation on the farm must be assessed through laboratory testing. In line with this, various PRRS elimination or stabilization projects have been implemented at the regional level since 2009, leading to an increase in the number of diagnostic tests. Furthermore, PRRS causes greater damage when combined with other respiratory diseases than when isolated, necessitating accurate diagnosis and vaccination. Consequently, demand for diagnostic tests capable of detecting trace amounts of PRRSv in the blood is increasing.
[0009]
[0010] The mutation rate of PRRSv is approximately 4.71*10 2 and 9.8*10 2 The probability of a single mutation occurring per year of viral replication is approximately 1 million times higher than the mutation rate of SARS-CoV. This high mutation rate increases the emergence of new variant viruses, ultimately hindering cross-protection even between identical genotypes, making PRRS prevention and eradication difficult.
[0011]
[0012] The most commonly used specimens for diagnosing PRRSv are lung tissue and blood. RNA is extracted from the lungs and blood, and reverse transcriptase polymerase chain reaction (RT-PCR) is performed. Then, they are identified using molecular biological diagnostic techniques such as restriction fragment length polymorphism (RFLP), polymerase chain reaction (PCR), or quantitative PCR (qPCR). However, as mentioned above, there is still a lack of development of molecular biological diagnostic techniques that reflect the high mutation rate, mutations of PRRSv in each country, and field needs. In addition, there is a disadvantage that false negative results may occur when mutations occur in the primer and probe attachment sites.
[0013]
[0014] Meanwhile, as a prior art related to the present invention, registered patent No. 10-1942098 (Title of invention: Rapid kit for diagnosis of porcine reproductive and respiratory syndrome virus-specific antibody, registration date: January 18, 2019) has been disclosed.
[0015]
[0016] The background technology described above is technical information that the inventor possessed for the purpose of deriving the present invention or acquired in the process of deriving the present invention, and cannot necessarily be said to be publicly known technology disclosed to the general public prior to the application for the present invention.
[0017] The present invention has been proposed to solve the above-mentioned problems of the existing proposed methods, and its purpose is to provide a composition for testing porcine reproductive and respiratory syndrome virus, a test kit, and a test method using the same, which can effectively test and determine the type of porcine reproductive and respiratory syndrome virus, which frequently undergoes mutations.
[0018]
[0019] However, the technical problem to be achieved by the present invention is not limited to the technical problem described above, and other technical problems may exist, and even if not explicitly mentioned, the purpose or effect that can be understood from the solution or embodiment of the problem is also included.
[0020] The composition for testing porcine reproductive and respiratory syndrome virus according to the characteristics of the present invention to achieve the above-mentioned purpose is,
[0021] A composition for testing porcine reproductive and respiratory syndrome virus (PRRSv),
[0022] It is characterized in that it comprises a first probe for diagnosing PRRSv type 1 represented by the base sequence of sequence number 2 and a second probe for diagnosing PRRSv type 2 represented by the base sequence of sequence number 5.
[0023]
[0024] Preferably,
[0025] It may further include a first primer pair consisting of a primer represented by the base sequence of sequence number 1 and a primer represented by the base sequence of sequence number 3, and a second primer pair consisting of a primer represented by the base sequence of sequence number 4 and a primer represented by the base sequence of sequence number 6.
[0026]
[0027] Preferably,
[0028] It is represented by the base sequence of sequence number 8, and may further include a third probe for confirming the purity and concentration of the sample used for testing.
[0029]
[0030] More preferably,
[0031] It may further include a third pair of primers for confirmation, comprising a primer represented by the base sequence of sequence number 7 and a primer represented by the base sequence of sequence number 9.
[0032]
[0033] The porcine reproductive and respiratory syndrome virus test kit according to the features of the present invention to achieve the above-mentioned purpose is:
[0034] As a kit for testing porcine reproductive and respiratory syndrome virus (PRRSv),
[0035] It is characterized in that it comprises a first probe for diagnosing PRRSv type 1 represented by the base sequence of sequence number 2 and a second probe for diagnosing PRRSv type 2 represented by the base sequence of sequence number 5.
[0036]
[0037] Preferably,
[0038] It may further include a first primer pair consisting of a primer represented by the base sequence of sequence number 1 and a primer represented by the base sequence of sequence number 3, and a second primer pair consisting of a primer represented by the base sequence of sequence number 4 and a primer represented by the base sequence of sequence number 6.
[0039]
[0040] A method for testing porcine reproductive and respiratory syndrome virus using a composition for testing porcine reproductive and respiratory syndrome virus according to the characteristics of the present invention to achieve the above-mentioned purpose is as follows:
[0041] As a method for testing porcine reproductive and respiratory syndrome virus (PRRSv),
[0042] The composition comprises a first probe for diagnosing PRRSv type 1 represented by the base sequence of sequence number 2 and a second probe for diagnosing PRRSv type 2 represented by the base sequence of sequence number 5, and performs RT-qPCR (Reverse-Transcriptase quantitative Polymerase Chain Reaction) to test for PRRSv in a specimen and determine the type of PRRSv.
[0043]
[0044] Preferably, the composition for testing comprises:
[0045] It may further include a first primer pair consisting of a primer represented by the base sequence of sequence number 1 and a primer represented by the base sequence of sequence number 3, and a second primer pair consisting of a primer represented by the base sequence of sequence number 4 and a primer represented by the base sequence of sequence number 6.
[0046] According to the composition for testing porcine reproductive and respiratory syndrome virus, the test kit and the test method using the same proposed in the present invention, it is possible to effectively test for porcine reproductive and respiratory syndrome virus, which undergoes many mutations, and determine its type.
[0047]
[0048] In addition, the various advantageous advantages and effects of the present invention are not limited to the above-described contents, and will be more easily understood in the process of explaining specific embodiments of the present invention.
[0049] FIG. 1 is a drawing showing the results of a sensitivity measurement of PRRSv type 1 in a sensitivity measurement experiment of a composition for testing porcine reproductive and respiratory syndrome virus, a test kit, and a test method using the same according to one embodiment of the present invention.
[0050] FIG. 2 is a drawing showing the results of a sensitivity measurement of PRRSv type 2 in a sensitivity measurement experiment of a composition for testing porcine reproductive and respiratory syndrome virus, a test kit, and a test method using the same according to one embodiment of the present invention.
[0051] FIG. 3 is a drawing showing the results of sensitivity measurement of GAPDH in a sensitivity measurement experiment of a composition for testing porcine reproductive and respiratory syndrome virus, a test kit, and a test method using the same according to one embodiment of the present invention.
[0052] Below, with reference to the attached drawings, embodiments of the present invention are described in detail so that those skilled in the art can easily implement them. However, the present invention may be implemented in various different forms and is not limited to the embodiments described herein. In the drawings, irrelevant parts have been omitted for clarity of description, and similar reference numerals have been used throughout the specification to indicate similar parts.
[0053]
[0054] Throughout the specification, when a part is said to be "connected" to another part, this includes not only the case where it is "directly connected" but also the case where it is "indirectly connected" with another element in between. Furthermore, when a part is said to "include" a component, this should be understood to mean that, unless specifically stated to the contrary, it may include other components rather than excluding them, and does not preclude the presence or addition of one or more other features, numbers, steps, operations, components, parts, or combinations thereof.
[0055]
[0056] The following examples are provided as detailed explanations to aid understanding of the present invention and do not limit the scope of the invention. Therefore, inventions with the same scope and function as the present invention are also within the scope of the present invention.
[0057]
[0058] In addition, each configuration, process, procedure or method included in each embodiment of the present invention may be shared within a scope that is not technically inconsistent with each other.
[0059]
[0060] Additionally, some of the operations or functions described as being performed by a terminal, apparatus, or device in the present invention may instead be performed by a server connected to the terminal, apparatus, or device. Similarly, some of the operations or functions described as being performed by a server may also be performed by a terminal, apparatus, or device connected to the server.
[0061]
[0062] In particular, a means for executing a system according to each embodiment of the present invention may be an application or a web server, and a terminal that is a means for reading a recording medium recording the application or web server may include not only a general PC such as a general desktop or laptop, but also a mobile terminal such as a smart phone or tablet PC.
[0063]
[0064] Hereinafter, embodiments of the present invention will be described in detail with reference to the attached drawings.
[0065]
[0066] The present invention relates to a composition for testing porcine reproductive and respiratory syndrome virus (PRRSv), and more specifically, to a composition for testing porcine reproductive and respiratory syndrome virus, characterized in that it comprises a first probe for diagnosing PRRSv type 1 represented by the base sequence of SEQ ID NO: 2 and a second probe for diagnosing PRRSv type 2 represented by the base sequence of SEQ ID NO: 5.
[0067]
[0068] Here, the composition for testing may further include a first primer pair consisting of a primer represented by the base sequence of sequence number 1 and a primer represented by the base sequence of sequence number 3, and a second primer pair consisting of a primer represented by the base sequence of sequence number 4 and a primer represented by the base sequence of sequence number 6.
[0069]
[0070] In the present invention, primers and probes are designed to diagnose PRRSv, which has a high mutation rate, as much as possible compared to existing diagnostic methods. A test composition including the designed primers and probe can distinguish between Type 1 (European, EU (European)) and Type 2 (North American, NA (North American)) PRRSv, and can identify a control marker for RNA extraction. Using this test composition, PRRSv can be diagnosed by performing RT-qPCR (Reverse-transcriptase quantitative polymerase chain reaction).
[0071]
[0072] In the present invention, based on 1,024 PRRSv whole-genome sequences in the database of the National Center for Biotechnology Information in the United States, the base sequence regions that can diagnose PRRSv types 1 and 2 were analyzed. Through this, the overall type 1 was identified at 82.27-91.82% and the type 2 was identified at 94.2-96.83% or more (since this is the probability that the primers and probes and the PRRSv sequences are 100% identical, a higher discrimination level is possible).
[0073]
[0074] Additionally, the composition for testing may further include a third probe for confirming the purity and concentration of a sample used for testing, represented by the base sequence of SEQ ID NO: 8, and may further include a third primer pair for confirmation, consisting of a primer represented by the base sequence of SEQ ID NO: 7 and a primer represented by the base sequence of SEQ ID NO: 9.
[0075]
[0076] Here, the third probe and the third primer pair are configured to detect a pig housekeeping gene, and by additionally including the third probe and the third primer pair, it is possible to confirm whether the purity and concentration of RNA extracted from a pig-derived specimen sample are suitable for the experiment. More specifically, the third probe may detect GAPDH, which is one of the pig housekeeping genes. Through an experiment using a test composition further including the third probe and the third primer pair, it was confirmed that PRRSv types 1 and 2 can be effectively differentiated and diagnosed.
[0077]
[0078] Meanwhile, the present invention relates to a kit for testing porcine reproductive and respiratory syndrome virus, characterized in that it comprises a first probe for diagnosing PRRSv type 1 represented by the base sequence of SEQ ID NO: 2 and a second probe for diagnosing PRRSv type 2 represented by the base sequence of SEQ ID NO: 5. In addition, the test kit may further include a first primer pair consisting of a primer represented by the base sequence of SEQ ID NO: 1 and a primer represented by the base sequence of SEQ ID NO: 3, and a second primer pair consisting of a primer represented by the base sequence of SEQ ID NO: 4 and a primer represented by the base sequence of SEQ ID NO: 6, and may further include a third probe for confirming the purity and concentration of a sample used for testing, represented by the base sequence of SEQ ID NO: 8, and a third primer pair for confirmation consisting of a primer represented by the base sequence of SEQ ID NO: 7 and a primer represented by the base sequence of SEQ ID NO: 9.
[0079]
[0080] Meanwhile, the present invention is a method for testing porcine reproductive and respiratory syndrome virus, wherein a composition or test kit for testing porcine reproductive and respiratory syndrome virus, comprising a first probe for diagnosing PRRSv type 1 represented by the base sequence of sequence number 2 and a second probe for diagnosing PRRSv type 2 represented by the base sequence of sequence number 5, is used to test for PRRSv from a specimen and determine the type of PRRSv by performing RT-qPCR (Reverse-Transcriptase quantitative Polymerase Chain Reaction).
[0081]
[0082] Thus, the present invention relates to a one-step RT-qPCR differential diagnostic technique that reflects the clinical demand for effectively differentiating PRRSv, which is prevalent worldwide, regardless of country or region.
[0083]
[0084] Hereinafter, the present invention will be described in more detail through examples. These examples are intended solely to illustrate the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples.
[0085]
[0086] Example 1. Design of probe and primer pairs for PRRSv
[0087]
[0088] By comparing the PRRSv whole genome registered in the database of the National Center for Biotechnology Information in the United States, the regions with the least sequence variation were analyzed, and the regions that can best diagnose PRRSv were designed as PRRSv-specific primers and probes as shown in Table 1 below. For multi-color signals, a reporter was conjugated to the 5' end of the probes of SEQ ID NO: 2, SEQ ID NO: 5, and SEQ ID NO: 8, and a quencher was conjugated to the 3' end, respectively.
[0089]
[0090]
[0091] In Table 1, PRRSv EU_F, PRRSv EU_P, and PRRSv EU_R corresponding to sequence numbers 1 to 3 are primer and probe sets that can diagnose PRRSv type 1 (EU), and PRRSv NA_F, PRRSv NA_P, and PRRSv NA_R corresponding to sequence numbers 4 to 6 are primer and probe sets that can diagnose PRRSv type 2 (NA). In addition, Sus_GAPDH_F, Sus_GAPDH_P, and Sus_GAPDH_R corresponding to sequence numbers 7 to 9 in Table 1 are primer and probe sets that can identify GAPDH, one of the cell maintenance genes of pigs, and are a set that can confirm whether the purity and concentration of sample RNA used for RT-qPCR diagnosis are suitable for the experiment. Here, the scale / purification of the probe Sus_GAPDH_P of sequence number 8 is 100 nmole / HPLC.
[0092]
[0093] Experimental Example 1. Coverage Evaluation
[0094]
[0095] Among the PRRSv sequence database registered in the National Center for Biotechnology Information database in the United States, 1,024 whole genomes with accurately classified ORF (open reading frame) information were selected for analysis, excluding data with partially registered ORF information. The 1,024 whole genomes consist of 110 PRRSv type 1 (EU) whole genomes and 914 PRRSv type 2 (NA) whole genomes.
[0096]
[0097] The coverage of primers and probes was evaluated by the number of base pairs that matched 100%, mismatched 1, and mismatched 2 times with the base sequence of the entire genome, and the results are shown in Table 2 below. In addition to the primer and probe pairs of Example 1 of the present invention (indicated in bold), the coverage of primers and probes targeting PRRSv in three papers was also evaluated.
[0098]
[0099] As a result of coverage comparison, it was confirmed that the primer and probe pair of the present invention had the highest 100% match coverage, and it was confirmed that there were no more than two mismatch parts except for PRRSv_EU_P.
[0100]
[0101]
[0102] **Reference PMID number: 25766790 (Reference 1), 22768042 (Reference 2), 36042510 (Reference 3)
[0103]
[0104] Experimental Example 2. Sensitivity Evaluation of Primer and Probe Sets
[0105]
[0106] Serial dilutions (10) of the primer and probe sets produced in Example 1 and the synthetic genes of PRRSv type 1 and type 2 6 ~10 1 Using a RT-qPCR assay (copies / test), the sensitivity to PRRSv types 1 and 2 was evaluated under the conditions of Table 3 (Composition and conditions for RT-qPCR) and Table 4 (Diagnostic method).
[0107]
[0108]
[0109]
[0110]
[0111]
[0112] FIG. 1 is a drawing showing the results of the sensitivity measurement of PRRSv type 1 in a sensitivity measurement experiment of a composition for testing porcine reproductive and respiratory syndrome virus, a test kit, and a test method using the same according to an embodiment of the present invention, FIG. 2 is a drawing showing the results of the sensitivity measurement of PRRSv type 2 in a sensitivity measurement experiment of a composition for testing porcine reproductive and respiratory syndrome virus, a test kit, and a test method using the same according to an embodiment of the present invention, and FIG. 3 is a drawing showing the results of the sensitivity measurement of GAPDH in a sensitivity measurement experiment of a composition for testing porcine reproductive and respiratory syndrome virus, a test kit, and a test method using the same according to an embodiment of the present invention. FIGS. 1 to 3 are graphs showing the results of measuring sensitivity by serially diluting a synthetic gene (Plasmid). Specific sensitivity measurement Ct values are as shown in Table 5 below. As can be seen in Table 5 and FIGS. 1 to 3, according to the present invention, both PRRSv type 1 and type 2 are 10 2 It can even detect copies.
[0113]
[0114]
[0115] * In the case of GAPDH, the same concentration is 10 5 Proceed by mixing with copies
[0116]
[0117] Experimental Example 3. Evaluation of PRRSv vaccine and other porcine respiratory viruses and bacteria
[0118]
[0119] RT-qPCR was performed on four commercially available PRRSv vaccines and six porcine respiratory viruses and bacteria other than PRRSv. The PRRSv vaccines showed consistent typologies and diagnostic results, while the diagnostic results for porcine respiratory viruses and bacteria other than PRRSv were all negative (Table 6).
[0120]
[0121]
[0122]
[0123] Experimental Example 4. Sanger sequencing of farm samples and comparative evaluation with third-party products.
[0124]
[0125] Median's VDx on 211 farm samples collected from managed farms ® PRRSV qRT-PCR (NA / EUdual) kit (A), PowerChek from Kogene TM A comparative experiment was conducted with the test kit (C) according to Example 1 of the present invention together with the PRRSv (EU / NA) Realtime PCR kit (B), and the results of sanger sequencing of the ORF5 gene of PRRSv, which is the golden standard, were compared for 43 out of 211 cases.
[0126]
[0127] Table 7 shows the Sanger sequencing results for 43 farm samples and the results of three assays, and Table 8 compares the sensitivity, specificity, and diagnostic agreement based on the standard Sanger sequencing results.
[0128]
[0129]
[0130] * A: VDx from Median ®PRRSV qRT-PCR (NA / EUdual) kit, B: PowerChek TM PRRSv from Kogene, C: Test kit according to Example 1 of the present invention
[0131]
[0132]
[0133] * A: VDx from Median ® PRRSV qRT-PCR (NA / EUdual) kit, B: PowerChek TM PRRSv from Kogene, C: Test kit according to Example 1 of the present invention
[0134]
[0135] As can be seen in Table 8, when comparing 43 out of 211 farm samples that underwent sanger sequencing with A, B, and the present invention (C), for PRRSv type 1, A showed a sensitivity of 90.91%, a specificity of 100%, and a diagnostic agreement of 95.3%, B showed a sensitivity of 100%, a specificity of 42.86%, and a diagnostic agreement of 72.1%, and C showed a sensitivity of 100%, a specificity of 95.24%, and a diagnostic agreement of 97.7%. For PRRSv type 2, A showed a sensitivity of 92.00%, a specificity of 91.44%, and a diagnostic agreement of 93%; B showed a sensitivity of 88%, a specificity of 94.44%, and a diagnostic agreement of 90.7%; and C showed a sensitivity of 96%, a specificity of 100%, and a diagnostic agreement of 97.7%.
[0136]
[0137] Table 9 below shows the diagnostic results for all 211 farm samples, and Table 10 compares the sensitivity and specificity of B and the present invention (C) based on A.
[0138]
[0139]
[0140] *If PRRSv type 1 and type 2 are detected simultaneously
[0141] ** A: VDx from Median ® PRRSV qRT-PCR (NA / EUdual) kit, B: PowerChek TM PRRSv from Kogene, C: Test kit according to Example 1 of the present invention
[0142]
[0143]
[0144] * A: VDx from Median ® PRRSV qRT-PCR (NA / EUdual) kit, B: PowerChek TM PRRSv from Kogene, C: Test kit according to Example 1 of the present invention
[0145]
[0146] As can be seen in Table 10, when comparing B and the present invention (C) based on the results of A for 211 farm samples, for PRRSv type 1, B showed a sensitivity of 92.85%, a specificity of 44.97%, and a diagnostic agreement of 54.5%, and C showed a sensitivity of 100%, a specificity of 97.04%, and a diagnostic agreement of 97.6%. For PRRSv type 2, B showed a sensitivity of 75.00%, a specificity of 91.87%, and a diagnostic agreement of 84.8%, and C showed a sensitivity of 90.91%, a specificity of 91.87%, and a diagnostic agreement of 91.5%.
[0147]
[0148] Through these results, it was confirmed that the present invention (C) is not only the method most consistent with the results of the standard Sanger sequencing, but also capable of making an accurate diagnosis, compared to the currently commercialized diagnostic kits A and B.
[0149]
[0150] As described above, according to the composition for testing porcine reproductive and respiratory syndrome virus, the test kit and the test method using the same proposed in the present invention, it is possible to effectively test for porcine reproductive and respiratory syndrome virus, which undergoes many mutations, and determine its type.
[0151]
[0152] The foregoing description of the present invention is provided for illustrative purposes only, and those skilled in the art will readily appreciate that the present invention can be readily modified into other specific forms without altering the technical spirit or essential characteristics of the present invention. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive. For example, each component described as a single entity may be implemented in a distributed manner, and similarly, components described as distributed may be implemented in a combined manner.
[0153]
[0154] The scope of the present invention is indicated by the claims described below rather than the detailed description above, and all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts should be interpreted as being included in the scope of the present invention.
Claims
1. A composition for testing porcine reproductive and respiratory syndrome virus (PRRSv), A first primer pair comprising a first probe for diagnosing PRRSv type 1 represented by the base sequence of sequence number 2 and a primer represented by the base sequence of sequence number 1 and a primer represented by the base sequence of sequence number 3, and a second probe for diagnosing PRRSv type 2 represented by the base sequence of sequence number 5 and a second primer pair comprising a primer represented by the base sequence of sequence number 4 and a primer represented by the base sequence of sequence number 6, A composition for testing for porcine reproductive and respiratory syndrome virus, characterized in that it further comprises a third probe for confirming the purity and concentration of a sample used for testing, represented by the base sequence of sequence number 8, and a third primer pair for confirmation, consisting of a primer represented by the base sequence of sequence number 7 and a primer represented by the base sequence of sequence number 9.
2. As a kit for testing porcine reproductive and respiratory syndrome virus (PRRSv), A first primer pair comprising a first probe for diagnosing PRRSv type 1 represented by the base sequence of sequence number 2 and a primer represented by the base sequence of sequence number 1 and a primer represented by the base sequence of sequence number 3, and a second probe for diagnosing PRRSv type 2 represented by the base sequence of sequence number 5 and a second primer pair comprising a primer represented by the base sequence of sequence number 4 and a primer represented by the base sequence of sequence number 6, A kit for testing for porcine reproductive and respiratory syndrome virus, characterized in that it further comprises a third probe for confirming the purity and concentration of a sample used for testing, represented by the base sequence of sequence number 8, and a third primer pair for confirmation, consisting of a primer represented by the base sequence of sequence number 7 and a primer represented by the base sequence of sequence number 9.
3. As a method for testing porcine reproductive and respiratory syndrome virus (PRRSv), A method for testing porcine reproductive and respiratory syndrome virus, characterized in that the composition for testing porcine reproductive and respiratory syndrome virus comprises a first probe for diagnosing PRRSv type 1 represented by the base sequence of SEQ ID NO: 2, a first primer pair comprising a primer represented by the base sequence of SEQ ID NO: 1 and a primer represented by the base sequence of SEQ ID NO: 3, and a second probe for diagnosing PRRSv type 2 represented by the base sequence of SEQ ID NO: 5, a second primer pair comprising a primer represented by the base sequence of SEQ ID NO: 4 and a primer represented by the base sequence of SEQ ID NO: 6, and further comprises a third probe for confirming the purity and concentration of a sample used for testing represented by the base sequence of SEQ ID NO: 8, and a third primer pair for confirmation comprising a primer represented by the base sequence of SEQ ID NO: 7 and a primer represented by the base sequence of SEQ ID NO: 9, thereby testing for PRRSv in a specimen sample and determining the type of PRRSv.
Citation Information
Patent Citations
Composition for testing PRRS virus and test kit, test method using thereof
KR102650676B1
KR20200069603A
